Dublin, Feb. 07, 2025 (GLOBE NEWSWIRE) — The “Trypsin Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F” report has been added to ResearchAndMarkets.com’s offering.
The Trypsin Market was valued at USD 94.23 Million in 2024, and is expected to reach USD 133.01 Million by 2030, rising at a CAGR of 5.87%. The global trypsin market, driven by its extensive applications in the pharmaceutical, biotechnology, and food industries, is projected to experience significant growth in the coming years. The increasing prevalence of chronic diseases and the rising demand for effective treatments are key factors fueling the need for trypsin.
The market’s growth trajectory is supported by expanding applications across various industries and technological advancements that enhance production efficiency. A notable trend is the shift towards microbial and recombinant trypsin production, which is expected to address the challenges associated with animal-derived sources, ensuring a stable and sustainable supply. Furthermore, the growing focus on biopharmaceuticals and the increasing demand for protein-based therapeutics are set to drive further market expansion.
North America emerged as the dominant region in the global trypsin market in 2024, holding the largest market share in terms of value. North America, particularly the United States, hosts a substantial number of biopharmaceutical companies engaged in drug discovery, development, and manufacturing. These companies drive the demand for trypsin, which is essential in bioprocessing for producing therapeutic proteins, monoclonal antibodies, vaccines, and other biologics. The concentration of biopharmaceutical firms in North America amplifies the region’s demand for high-quality trypsin.
Major biotechnology innovation hubs, such as Boston, San Francisco, and San Diego, are located in North America. These clusters foster collaboration between research institutions, universities, startups, and established biotech companies. The innovative environment encourages the adoption of cutting-edge technologies and products, including advanced enzymes like trypsin, which are integral to biotechnological advancements. North America leads in research and development (R&D) expenditure across biotechnology and pharmaceutical sectors. The region’s commitment to innovation and technological advancement drives continuous improvements in bioprocessing techniques, analytical methodologies, and therapeutic applications.
Trypsin’s role in proteomics, genomics, and cell culture research aligns with North America’s focus on advancing biomedical sciences and translating research into commercial products. North America boasts renowned academic and research institutions that conduct groundbreaking research in biotechnology, medicine, and life sciences. These institutions collaborate closely with industry partners to develop new therapies, diagnostic tools, and bioprocess technologies. The demand for trypsin in academic research and institutional settings further contributes to North America’s leadership in the global market.
Key Market Drivers
- Expansion of Biopharmaceuticals
- Increasing Prevalence of Chronic Diseases
- Advancements in Biotechnology
Key Market Challenges
- Regulatory Hurdles and Compliance Issues
- High Production Costs and Economic Constraints
- Supply Chain Disruptions and Reliability Issues
Key Market Trends
- Shift Toward Recombinant and Microbial Trypsin Production
- Growing Application in Biopharmaceuticals and Cell Culture Technologies
- Integration with High-Throughput Screening and Automation
Key Trypsin Market Players Profiled
- Merck KGaA (Millipore)
- Novozymes A/S, part of Novonesis Group
- Agilent Technologies, Inc.
- Thermo Fisher Scientific Inc.
- Sartorius AG
- Bioseutica B.V.
- Biozym Scientific GmbH
- PromoCell GmbH
- Promega Corporation
- Bovogen Biologicals Pty. Ltd.
Report Scope
Trypsin Market, By Source:
Trypsin Market, By Application:
- Biotechnology and Pharmaceutical Industry
- Food Industry
- Cosmetics and Personal Care
- Waste Treatment
- Others
Trypsin Market, By End User:
- Research
- Diagnostics
- Industrial use
Trypsin Market, By Region:
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Key Attributes
| Report Attribute | Details |
| No. of Pages | 180 |
| Forecast Period | 2024-2030 |
| Estimated Market Value (USD) in 2024 | $94.23 Million |
| Forecasted Market Value (USD) by 2030 | $133.01 Million |
| Compound Annual Growth Rate | 5.8% |
| Regions Covered | Global |
For more information about this report visit https://www.researchandmarkets.com/r/leg0sm
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
